Skip to main content

Table 1 Number and % of subjects with mutations in IPAT genes; PSP genes and at least one gene (IPAT & PSP) in: patients with CF and recurrent/chronic pancreatitis (RP/CP); patients with CF without pancreatitis and healthy subjects

From: Trans-heterozygosity for mutations enhances the risk of recurrent/chronic pancreatitis in patients with Cystic Fibrosis

 

n of cases

IPAT

PSP

IPAT & PSP

CF and RP/CP

48

14 (29.2)

11 (22.9)

19 (39.6)

CF without pancreatitis

35

2 (5.7)

3 (8.5)

4 (11.4)

healthy subjects

80

3 (3.8)

8 (10)

11 (13.7)

Chi square and (p)

 

20.4 (p < 0.001)

4.39 (p = 0.11)

14.5 (p < 0.001)